Company Filing History:
1 out of 1,036 
1 out of 2,893 
Years Active: 2014
Title: Adam S Feldman: Innovator in Cancer Diagnosis
Introduction
Adam S Feldman is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer diagnosis, particularly focusing on epithelial cancers. His innovative work has led to the development of methods that enhance the diagnosis and prognosis of these types of cancers.
Latest Patents
Feldman's most recent patent is titled "Method for diagnosis and prognosis of epithelial cancers." This invention is based on the discovery that three proteins—Cystatin B, Chaperonin 10, and Profilin—are present in the urine of patients with bladder cancer, which is a cancer of epithelial origin. The patent outlines methods for prognostic evaluation and diagnosis of cancers of epithelial origin by monitoring these markers in biological samples. Additionally, the invention addresses markers for therapeutic efficacy. He holds 1 patent in this area.
Career Highlights
Throughout his career, Adam S Feldman has worked with prominent organizations, including Children's Medical Center Corporation and The General Hospital Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Feldman has collaborated with notable colleagues such as Bruce R Zetter and W Scott McDougal. Their combined expertise has contributed to advancements in cancer diagnosis and treatment.
Conclusion
Adam S Feldman's innovative work in cancer diagnosis exemplifies the impact of research and invention in the medical field. His contributions continue to pave the way for improved diagnostic methods for epithelial cancers.